Clinically Significant Intraocular Lens Decentration and Tilt in Highly Myopic Eyes: A Swept-Source Optical Coherence Tomography Study
Clinically Significant Intraocular Lens Decentration and Tilt in Highly Myopic Eyes: A Swept-Source Optical Coherence Tomography Study
复制标题
DOI:
10.1016/j.ajo.2021.08.017
复制
发表时间:
2021-11-27
影响因子:
4.2
通讯作者:
Liu, Yizhi
中科院分区:
文献类型:
--
作者:
Wang, Lanhua;Jin, Guangming;Liu, Yizhi
PURPOSE: To investigate the occurrence and risk factors of clinically significant intraocular lens (IOL) decentration and tilt in highly myopic eyes using swept-source anterior segment optical coherence tomography (SS-AS-OCT).DESIGN: Cross-sectional study.METHODS: This study included 334 participants (334 eyes) with high myopia, defined as axial length (AL) >= 26 mm, who underwent phacoemulsification with IOL implantation. Decentration and tilt of IOL were assessed by SS-AS-OCT. Clinically significant IOL decentration and tilt was defined as decentration >= 0.4 mm and tilt >= 7 degrees. Routine preoperative and postoperative examinations included visual acuity, refraction, biometric measurement using IOLMaster 700 (Carl Zeiss Meditec), and objective visual quality evaluated by OPD-Scan III (Nidek Technologies).RESULTS: Among the 334 highly myopic participants, 71 (21.3%) had clinically significant IOL decentration, and 26 (7.78%) had clinically significant IOL tilt. The proportion of clinically significant IOL decentration (37.1% vs 14.0%, P < .001) and tilt (16.2% vs 3.90%, P < .001) in those with AL >= 30 mm was significantly higher than in those with AL = 30 mm was associated with clinically significant IOL decentration (odds ratio, 1.65; P = .002). AL >= 30 mm (odds ratio, 2.09; P = .001) was an independent risk factor for clinically significant IOL tilt after adjusting for confounders. AL >= 30.3 mm could effectively predict IOL decentration >= 0.6 mm (area under the curve, 0.802).CONCLUSIONS: Participants with AL >30 mm have a higher risk of clinically significant IOL decentration and tilt, thus caution should be taken to implant multifocal or toric IOL for these patients.(C) 2021 Elsevier Inc. All rights reserved.